The programme was started at six centres in Tamil Nadu

The Chennai-based National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre) has started a pilot testing programme of providing for six months isoniazid TB drug as prophylactic to HIV-positive individuals. People recruited will include those on antiretroviral therapy (ART) too. The programme was started about two months ago at six centres in Tamil Nadu (including two ART centres in Chennai) and it got under way recently in Bangalore, New Delhi and Hyderabad. The ART centres were chosen by the National AIDS Control Organisation (NACO).